Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Revance Therapeutics Inc (NASDAQ: RVNC) closed the day trading at $3.03 down -20.68% from the previous closing price of $3.82. In other words, the price has decreased by -$20.68 from its previous closing price. On the day, 22.72 million shares were traded. RVNC stock price reached its highest trading level at $3.05 during the session, while it also had its lowest trading level at $3.011.
Ratios:
For a better understanding of RVNC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.
On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.
Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when Hollander David sold 3,908 shares for $4.17 per share. The transaction valued at 16,296 led to the insider holds 104,945 shares of the business.
Jordan Erica sold 2,392 shares of RVNC for $9,096 on Apr 16 ’24. The Chief Commercial Officer now owns 114,864 shares after completing the transaction at $3.80 per share. On Mar 18 ’24, another insider, Sjuts Dustin S, who serves as the President of the company, sold 9,211 shares for $5.04 each. As a result, the insider received 46,446 and left with 167,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 317853056 and an Enterprise Value of 617225216. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.25. Its current Enterprise Value per Revenue stands at 2.402 whereas that against EBITDA is -3.29.
Stock Price History:
Over the past 52 weeks, RVNC has reached a high of $9.74, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is -36.33%, while the 200-Day Moving Average is calculated to be -32.79%.
Shares Statistics:
Over the past 3-months, RVNC traded about 2.87M shares per day on average, while over the past 10 days, RVNC traded about 1701620 shares per day. A total of 104.90M shares are outstanding, with a floating share count of 95.70M. Insiders hold about 8.77% of the company’s shares, while institutions hold 80.34% stake in the company. Shares short for RVNC as of 1731628800 were 12210780 with a Short Ratio of 4.26, compared to 1728950400 on 9194558. Therefore, it implies a Short% of Shares Outstanding of 12210780 and a Short% of Float of 13.350001.
